X. Li

ORCID: 0009-0005-5211-7678
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mycobacterium research and diagnosis
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Tuberculosis Research and Epidemiology
  • Cancer-related molecular mechanisms research
  • Parathyroid Disorders and Treatments
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Vascular Malformations and Hemangiomas
  • RNA modifications and cancer
  • NF-κB Signaling Pathways
  • Magnesium in Health and Disease
  • Platelet Disorders and Treatments
  • Natural Compounds in Disease Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Vascular Malformations Diagnosis and Treatment
  • Potassium and Related Disorders
  • Peptidase Inhibition and Analysis
  • Angiogenesis and VEGF in Cancer
  • Hepatitis C virus research

Nantong University
2023

Guangzhou Medical University
2015-2020

State Key Laboratory of Respiratory Disease
2015-2018

Guangzhou Chest Hospital
2018

Shandong Chest Hospital
2012

To investigate the prevalence of extensively drug-resistant tuberculosis (XDR-TB) in Chinese populations, we analyzed drug resistance profiles 1787 Mycobacterium isolates through a population-based surveillance project Shandong Province, China. We found 330 (18.5%; 95%CI 16.1-20.3) resistant to ≥1 first-line and 65 (3.6%; 2.9-4.6) multidrug-resistant (MDR) isolates, which 13 (20.0%; 11.9-31.4) were XDR; 47/65 MDR-TB (70.8%; 58.2-81.4) fluoroquinolones. Our results indicate that inadequate...

10.5588/ijtld.11.0507 article EN The International Journal of Tuberculosis and Lung Disease 2012-03-09
Coming Soon ...